With the new financial year upon us, investors may be wondering where to find the best opportunities on the ASX.
Let's take a look at 10 Aussie stocks that analysts are positive on as we head into FY 2026. They are as follows:
This gaming and technology powerhouse has impressed over the past decade with strong and consistent growth. And with its sizeable investment in research and development and content, it appears well-placed to build on this in FY 2026 and beyond.
Bell Potter is a fan and recently put a buy rating and $79.00 price target on this Aussie stock.
Rail freight operator Aurizon offers exposure to the nation's transport and logistics sector with a focus on coal, agriculture, and industrial freight. It is also a dividend payer with a big forecast yield which could appeal to income-focused investors.
Last week, Macquarie upgraded its shares to an outperform rating with a $3.39 price target.
Another Aussie stock to look at is Cochlear. It is a leader in hearing implant technology and has strong tailwinds from ageing global populations. Recent product launches and its R&D investment look set to cement its leadership position for a long time to come.
Analysts at UBS have a buy rating and $325.00 price target on its shares.
CSL is one of Australia's crown jewels in healthcare. With a world-class plasma therapy business and expanding vaccine and biotech capabilities, it is well-positioned to grow in FY 2026 and beyond. In fact, double-digit earnings growth is forecast by many analysts over the remainder of 2020s.
Bell Potter is bullish on CSL and has a buy rating and $305.00 price target on its shares.
As one of the world's largest industrial property companies, Goodman is tapping into strong demand for logistics and data centre infrastructure. Its global footprint and world class pipeline of projects make it a standout in the property sector.
Citi has a buy rating and $40.00 price target on its shares.
This network-as-a-service provider looks well-positioned for growth over the long term. This is thanks to its exposure to cloud computing and artificial intelligence trends. Morgans thinks it is "is uniquely placed to help business move data globally and benefit from the growth of data related to both cloud computing and AI."
The broker has an accumulate rating and $15.50 price target on Megaport's shares.
Another Aussie stock benefit from the AI boom is NextDC. As one of the Asia-Pacific's leading data centre operators, it is capitalising on the massive demand for data storage and connectivity. In fact, the company recently revealed a record pro forma forward order book of 135MW. This compares to its total contracted utilisation of 176MW during the first half.
The team at Macquarie has an outperform rating and $22.10 price target on its shares.
Lithium prices may have cooled off, but Pilbara Minerals is still profitable thanks to its quality assets and low costs. If sentiment turns and demand accelerates, it could be well placed to ride the next wave of the energy transition.
Macquarie is bullish on the lithium miner and has an outperform rating and $2.40 price target on its shares.
ResMed continues to benefit from long-term demand for sleep apnoea treatment and respiratory care. And with an estimated addressable market of over 1 billion people, it has decades of growth ahead of it.
Macquarie has an outperform rating and $48.00 price target on ResMed's shares.
Temple & Webster is the leader in online furniture and homewares. While consumer sentiment may remain soft in the near term, the structural shift online and its strong brand leave this Aussie stock well-positioned for growth in FY 2026 and beyond.
Morgan Stanley is bullish on its outlook. It has an overweight rating and $28.00 price target on its shares.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.